The role of lifestyle modification in polycystic ovary syndrome

Trends in Endocrinology and Metabolism

Volumn 13, Issue 6, 2002, Pages 251-257

  Norman, Robert J ^a   Davies, Michael J ^a   Lord, Jonathan ^b   Moran, Lisa J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ALCOHOL CONSUMPTION; ANOVULATION; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DIET THERAPY; ENDOCRINE DISEASE; EXERCISE; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE; MENTAL STRESS; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SOCIAL PROBLEM; WEIGHT REDUCTION; BEHAVIOR THERAPY; BODY COMPOSITION; DIET; DRINKING BEHAVIOR; GLUCOSE INTOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ALCOHOL DRINKING; BEHAVIOR THERAPY; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LIFE STYLE; OBESITY; POLYCYSTIC OVARY SYNDROME; SMOKING; WEIGHT LOSS;

EID: 0036675187     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(02)00612-4     Document Type: Review

References (61)

1. Lobo, R.A. and Carmina, E. (2000) The importance of diagnosing the polycystic ovary syndrome. Ann. Intern. Med. 132, 989-993
2. Reaven, G. (1999) Syndrome X: 10 years after. Drugs 58 (Suppl. 1), 19-20; discussion 75-82
3. Farquhar, C.M. et al. (1994) The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust. N. Z. J. Obstet. Gynaecol. 34, 67-72
4. Norman, R.J. et al. (1995) Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil. Steril. 63, 329-335
5. Zawdaki, J. and Dunaif, A. (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Polycystic Ovary Syndrome. Current Issues in Endocrinology and Metabolism (Vol. 4) (Dunaif, A. et al., eds), pp. 377-384, Blackwell Scientific
6. Diamanti-Kandarakis, E. et al. (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J. Clin. Endocrinol. Metab. 84, 4006-4011
7. Knochenhauer, E.S. et al. (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J. Clin. Endocrinol. Metab. 83, 3078-3082
8. Asuncion, M. et al. (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 85, 2434-2438
9. Legro, R.S. (1999) Polycystic ovary syndrome. Phenotype to genotype. Endocrinol. Metab. Clin. North Am. 28, 379-396
10. Legato, M.J. (1997) Gender-specific aspects of obesity. Int. J. Fertil. Womens Med. 42, 184-197
11. AIHW. (2000) Australia's Health 2000: The Seventh Biannual Health Report of the AIHW, Australian Institute of Health and Welfare
12. Rebuffe-Scrive, M. et al. (1989) Anthropometric variables and metabolism in polycystic ovarian disease. Horm. Metab. Res. 21, 391-397
13. Dunaif, A. (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18, 774-800
14. Abate, N. et al. (1995) Relationships of generalized and regional adiposity to insulin sensitivity in men. J. Clin. Invest. 96, 88-98
15. Despres, J.P. et al. (2001) Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 322, 716-720
16. Zaadstra, B.M. et al. (1993) Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ 306,484-487
17. Wang, J.X. et al. (2000) Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 321, 1320-1321
18. Ehrmann, D.A. et al. (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141-146
19. Legro, R.S. et al. (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84, 165-169
20. Weerakiet, S. et al. (2001) Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int. J. Gynaecol. Obstet. 75, 177-184
21. Norman, R.J. et al. (2001) Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum. Reprod. 16, 1995-1998
22. Barzilai, N. et al. (1999) Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48, 94-98
23. Lemieux, S. et al. (1996) Seven-year changes in body fat and visceral adipose tissue in women. Association with indexes of plasma glucose-insulin homeostasis. Diabetes Care 19, 983-991
24. Holte, J. et al. (1994) Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. Endocrinol. Metab. 78, 1052-1058
25. Kirchengast, S. and Huber, J. (2001) Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum. Reprod. 16, 1255-1260
26. Holte, J. et al. (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 80, 2586-2593
27. Iuorno, M.J. and Nestler, J.E. (2001) Insulin-lowering drugs in polycystic ovary syndrome. Obstet. Gynecol. Clin. North Am. 28, 153-164
28. Hoeger, K. (2001) Obesity and weight loss in polycystic ovary syndrome. Obstet. Gynecol. Clin. North Am. 28, 85-97
29. Andersen, P. et al. (1995) Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism 44, 611-616
30. Kiddy, D.S. et al. (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 36, 105-111
31. Pan, X.R. et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20, 537-544
32. Tuomilehto, J. et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl. J. Med. 344, 1343-1350
33. Hu, F.B. et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New Engl. J. Med. 345, 790-797
34. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl. J. Med. 346, 393-403
35. NIH (1998) Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: evidence report. J. Obesity Res. 6 (Suppl. 2), S51-S209
36. Anonymous. (2000) Case problem: dietary recommendations to combat obesity, insulin resistance, and other concerns related to polycystic ovary syndrome. J. Am. Dietetic Assoc. 100, 955-957; discussion 957-960
37. Mikkelsen, P.B. et al. (2000) Effect of fat-reduced diets on 24-h energy expenditure: comparisons between animal protein, vegetable protein, and carbohydrate. Am. J. Clin. Nutr. 72, 1135-1141
38. Piatti, P.M. et al. (1994) Hypocaloric high-protein diet improves glucose oxidation and spares lean body mass: comparison to hypocaloric high-carbohydrate diet. Metabolism 43, 1481-1487
39. Downey, J. et al. (1989) Mood disorders, psychiatric symptoms, and distress in women presenting for infertility evaluation. Fertil. Steril. 52, 425-432
40. Galletly, C. et al. (1996) Improved pregnancy rates for obese, infertile women following a group treatment program. An open pilot study. Gen. Hosp. Psychiatry 18, 192-195
41. Cronin, L. et al. (1998) Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J. Clin. Endocrinol. Metab. 83, 1976-1987
42. Caan, B. et al. (1998) Differences in fertility associated with caffeinated beverage consumption. Am. J. Public Health 88, 270-274
43. Curtis, K.M. et al. (1997) Effects of cigarette smoking, caffeine consumption, and alcohol intake on fecundability. Am. J. Epidemiol. 146, 32-41
44. Stanton, C.K. and Gray, R.H. (1995) Effects of caffeine consumption on delayed conception. Am. J. Epidemiol. 142, 1322-1329
45. Bolumar, F. et al. (1997) Caffeine intake and delayed conception: a European multicenter study on infertility and subfecundity. European Study Group of Infertility Subfecundity. Am. J. Epidemiol. 145, 324-334
46. Satcher, D. (2001) Women and Smoking. A Report of the Surgeon General. Centres for Disease Control
47. Grodstein, F. et al. (1994) Infertility in women and moderate alcohol use. Am. J. Public Health 84, 1429-1432
48. Jensen, T.K. et al. (1998) Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy. BMJ 317, 505-510
49. Olsen, J. et al. (1997) Does moderate alcohol intake reduce fecundability? A European multicenter study on infertility and subfecundity. European Study Group on Infertility and Subfecundity. Alcohol. Clin. Exp. Res. 21, 206-212
50. Flanagan, D.E. et al. (2000) Alcohol consumption and insulin resistance in young adults. Eur. J. Clin. Invest. 30, 297-301
51. Kiechl, S. et al. (1996) Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ 313, 1040-1044
52. Kovacs, G. and Wood, C. (2001) The current status of polycystic ovary syndrome. Aust. N. Z. J. Obstet. Gynaecol. 41, 65-68
53. Huber-Buchholz, M.M. et al. (1999) Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J. Clin. Endocrinol. Metab. 84, 1470-1474
54. Clark, A.M. et al. (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum. Reprod. 10, 2705-2712
55. Clark, A.M. et al. (1998) Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum. Reprod. 13, 1502-1505
56. Goldzieher, J.W. and Green, J.A. (1962) The polycystic ovary, I: clinical and histological features. J. Clin. Endocrinol. Metab. 22, 325-328
57. Kiddy, D.S. et al. (1990) Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin. Endocrinol. (Oxf.) 32, 213-220
58. Balen, A.H. et al. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod. 10, 2107-2111
59. Norman, R.J. and Clark, A.M. (1998) Obesity and reproductive disorders: a review. Reprod. Fertil. Dev. 10, 55-63
60. Dunaif, A. and Thomas, A. (2001) Current concepts in the polycystic ovary syndrome. Annu. Rev. Med. 52, 401-419
61. Norman, R.J. and Clark, A.M. (2000) Lifestyle factors in the aetiology and management of polycystic ovary syndrome. In Polycystic Ovary Syndrome (Kovacs, G.T. ed.), Cambridge University Press